Zobrazeno 1 - 9
of 9
pro vyhledávání: ''
Autor:
Alison Richards, Philippa Clery, Julian P T Higgins, Teona Serafimova, Caitlin L Ascough, Yasmin Moore, Parisa Sinai, Amberly Brigden, Hayley King, Esther Crawley, Nina Anderson
Publikováno v:
Archives of Disease in Childhood
Moore, Y, Serafimova, T, Anderson, N, King, H, Richards, A, Brigden, A L C, Sinai, P, Higgins, J P T, Ascough, C L, Clery, P & Crawley, E M 2021, ' Recovery from Chronic Fatigue Syndrome : a systematic review-heterogeneity of definition limits study comparison ', Archives of Disease in Childhood, vol. 106, no. 11, archdischild-2020-320196, pp. 1087-1094 . https://doi.org/10.1136/archdischild-2020-320196
Moore, Y, Serafimova, T, Anderson, N, King, H, Richards, A, Brigden, A L C, Sinai, P, Higgins, J P T, Ascough, C L, Clery, P & Crawley, E M 2021, ' Recovery from Chronic Fatigue Syndrome : a systematic review-heterogeneity of definition limits study comparison ', Archives of Disease in Childhood, vol. 106, no. 11, archdischild-2020-320196, pp. 1087-1094 . https://doi.org/10.1136/archdischild-2020-320196
Background Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a common illness with a major impact on quality of life. Recovery is poorly understood. Our aim was to describe definitions of recovery in paediatric CFS/ME, the
Autor:
Maurizio Bonati, Antonio Clavenna
Publikováno v:
Archives of disease in childhood. 99(9)
Objective To assess the long-term safety of drugs for attention deficit hyperactivity disorder (ADHD). Methods A bibliographic search was performed in the MEDLINE, EMBASE and PsycINFO databases for prospective studies evaluating the incidence of adve
Publikováno v:
Archives of Disease in Childhood. 83:330-333
AIM—To measure drug adherence in children with mild asthma receiving long term prophylactic treatment. METHODS—Double blind randomised placebo controlled trial. Patients received inhaled budesonide 100 µg or 200 µg daily, or placebo for 27 mont
Publikováno v:
Archives of Disease in Childhood. 80:110-114
BACKGROUND—Discharge planning is becoming an important part of the management of childhood asthma in hospital. Readmission to hospital, although often inevitable, might represent a failure of the opportunity for intervention presented by a brief pe
Publikováno v:
Archives of disease in childhood. 95(12)
Background The safety of long-acting β 2 agonist (LABA) therapy in asthma remains controversial but no large scale analyses have been published of LABA safety in children. Methods The frequency of asthma-related deaths and hospitalisations following
Publikováno v:
Archives of disease in childhood. 96(2)
Objective To determine whether Therapeutic Assessment (TA) versus assessment as usual (AAU) improves engagement with follow-up in adolescents presenting with self-harm. Design Randomised controlled trial with 3 months naturalistic follow-up. Setting
Publikováno v:
Archives of disease in childhood. 96(5)
Background In many cases standard management for chronic fatigue syndrome (CFS) in children and adolescents is ineffective. Objective To evaluate the efficacy of a video film intervention in preventing the development of persistent fatigue and signif
Publikováno v:
Archives of disease in childhood. 88(3)
Methotrexate (MTX) has transformed the outlook for children with juvenile idiopathic arthritis (JIA). Most of the evidence from uncontrolled clinical trials suggests that MTX is an effective agent for treating active JIA. Data from controlled clinica
Publikováno v:
Archives of disease in childhood. 80(5)
OBJECTIVES To compare the clinical effectiveness, acceptability, and cost benefit of administering β2 agonists by means of a metered dose inhaler and large volume spacer with conventional nebulisers to children admitted to hospital with acute asthma